SAS vs. SAS vs. Phoenix [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2019-11-12 13:01 (923 d 05:11 ago) – Posting: # 20788
Views: 6,150

Hi to all victims of the partial replicate with incomplete data,

following extensive off-list discussions with PharmCat (who is working on a [image] Julia-package; see here and there) I checked again what we got with the FDA’s covariance structure, Satterthwaite’s df (PE, 90% CI).
Not the slightest idea how I arrived at the results given above. Sorry for the confusion caused.
In all cases simplifying the covariance structure (in SAS-lingo FA0(1) instead of the FA0(2) in the guidance): Convergence without warning.

Dif-tor heh smusma 🖖 [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,092 posts in 4,630 threads, 1,567 registered users;
online 23 (0 registered, 23 guests [including 12 identified bots]).
Forum time: Monday 19:13 CEST (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5